A twice-yearly Human Immunodeficiency Virus prevention injection, hailed as the most promising tool against the virus in ...

Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, ...

New study findings could change treatments for HIV in young children. HIV remission may be possible for very young children ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

A total of 10 individuals with HIV have been cured to date. Most of these patients have remained anonymous, but three have ...

From influenza and COVID-19 to HIV, viruses continue to pose a serious danger to global health. But just as pressing are ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

Indian drugmakers Dr Reddy's Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and ...

Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those ...

Dr. Brandon Hill, CEO of Vivent Health and a researcher in HIV and sexual issues, talks about changes in government funding.

A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...